BIOGEN IDEC: Mediation on Medicaid MDL Proceedings Still Ongoing

Mediation on outstanding claims filed against Biogen Idec Inc. and its subsidiary Biogen Inc. (n/k/a Biogen Idec MA Inc.) over certain drugs for which Medicaid provides reimbursement (covered drugs) is still ongoing.

Along with several other major pharmaceutical and biotechnology…

BIOGEN IDEC: Contesting Mass. DOR’s 2001-2003 Tax Assessment

Biogen Idec Inc.’s wholly owned subsidiary, Biogen Idec MA, Inc., continues to contest the Massachusetts Department of Revenue’s US$38.9 million tax assessment.

On Sept. 12, 2006, the DOR issued a notice of assessment against Biogen Idec MA for US$38.9 million of…